Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. Long Term Debt 2020–2025
Xeris Biopharma Holdings, Inc. annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Xeris Biopharma Holdings, Inc. long term debt as of December 31, 2025: 220.3M, a 5.07% decrease year-over-year.
- Xeris Biopharma Holdings, Inc. long term debt for 2025 were 220.3M, a 5.07% decrease from 2024.
- Xeris Biopharma Holdings, Inc. long term debt for 2024 were 232.1M, a 21.57% increase from 2023.
- Xeris Biopharma Holdings, Inc. long term debt for 2023 were 190.9M, a 2.06% increase from 2022.
- Xeris Biopharma Holdings, Inc. long term debt for 2022 were 187.1M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Xeris Biopharma Holdings, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $220 |
| 2024 | $232 |
| 2023 | $191 |
| 2022 | $187 |
| 2021 | $88 |
| 2020 | $87 |
Xeris Biopharma Holdings, Inc. Long Term Debt — FAQ
Xeris Biopharma Holdings, Inc. (XERS) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XERS's long term debt history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s long term debt by year and by quarter, including the growth rate.